Renal Cell Carcinoma & Deep Invasive Tumor Thrombus: Predicting Surgical Complications
Radical nephrectomy and thrombectomy can effectively improve the prognosis of the 4% to 10% of...
Read MoreMar 8, 2022
Radical nephrectomy and thrombectomy can effectively improve the prognosis of the 4% to 10% of...
Read MoreFeb 25, 2022
While thoracoscopic sub-lobar resection (SR) appears to result in similar oncologic outcomes...
Read MoreFeb 11, 2022
Preoperative PET/CT provided information on standardized uptake value (SUV) and volumetric...
Read MoreFeb 8, 2022
The burden of stay-at-home mandates resulting from COVID-19 and the hesitancy of people to leave...
Read MoreFeb 7, 2022
In this study, bioinformatics methods were performed to screen the candidate prognosis-related...
Read MoreFeb 3, 2022
THURSDAY, Feb. 3, 2022 (HealthDay News) — A plasma assay that detects dysregulated lipids...
Read MoreFeb 1, 2022
A study published in the European Urology Oncology reports superior oncologic and safety benefits of adjuvant pembrolizumab compared with adjuvant tyrosine kinase inhibitors (TKIs) in patients treated with nephrectomy for...
Read MoreJan 31, 2022
Apigenin is a flavonoid widely presented in fruits and vegetables, and is known to possess anti‑inflammatory, antioxidant, and anticancer properties. The present study was designed to investigate the effects of apigenin on renal...
Read MoreJan 28, 2022
FRIDAY, Jan. 28, 2022 (HealthDay News) — Increased coffee intake is associated with a lower...
Read MoreJan 24, 2022
. Fumarate hydratase (FH)-deficient renal cell carcinoma (RCC) is a rare aggressive renal malignancy associated with hereditary leiomyomatosis and RCC syndrome (HLRCC). Tumors exhibiting heterogeneous (ie, patchy) FH loss by...
Read MoreJan 21, 2022
A research exhibited the contemporary approved approaches for the workup required to diagnose...
Read MoreJan 20, 2022
Women with advanced/recurrent endometrial cancer, especially those with the non-endometrioid (type...
Read MoreJan 17, 2022
In the CheckMate 9ER trial, patients with advanced renal cell carcinoma who received first-line nivolumab plus cabozantinib had significantly better progression-free survival compared with those given sunitinib. In this study,...
Read MoreJan 12, 2022
For a study, the researchers wanted to determine how time from diagnosis to treatment (TTI) affected viability in patients with non-metastatic non–small-cell lung cancer (NSCLC). Between 2004 and 2013, the National Cancer...
Read MoreJan 11, 2022
Ibrutinib was associated with prolonged progression-free survival (PFS) compared to the chemoimmunotherapy regimen bendamustine plus rituximab in older patients with treatment-naïve chronic lymphocytic leukemia (CLL). In...
Read MoreJan 6, 2022
Renal masses in kidney grafts provide a difficult clinical problem, as they must balance graft function with the necessity for cancer management. Cancers in the renal graft caused by donors can be classed as either ‘donor...
Read MoreJan 6, 2022
Renal cell carcinoma is the third most prevalent kind of urologic cancer. Because the first symptoms are often vague and late, the phases are often advanced when detected. As compensation, the discovery of RCC by abdominal...
Read MoreJan 6, 2022
Following the completion of genome-wide association studies, expression quantitative trait loci (eQTL) mapping studies are the most crucial step in genomics for identifying susceptibility genes and molecular pathways implicated...
Read MoreJan 6, 2022
Asthma is a widespread complicated disease with evident genetic predispositions, and prior genome-wide association studies suggest that the IL13 (interleukin 13) gene variant rs1295686 is significantly linked to asthma....
Read MoreJan 5, 2022
The purpose of the study was to look at the occurrence, predictors, and consequences of unexpected early postoperative readmission after lung resection for non–small cell lung cancer. The National Cancer Database collected data...
Read More